145 related articles for article (PubMed ID: 10395176)
1. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicities in mice and rats of IQ, MeIQ, and MeIQx.
Ohgaki H; Hasegawa H; Kato T; Suenaga M; Sato S; Takayama S; Sugimura T
Princess Takamatsu Symp; 1985; 16():97-105. PubMed ID: 3842704
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods.
Ohgaki H; Hasegawa H; Suenaga M; Sato S; Takayama S; Sugimura T
Carcinogenesis; 1987 May; 8(5):665-8. PubMed ID: 3581424
[TBL] [Abstract][Full Text] [Related]
5. Dose-response study of MeIQx carcinogenicity in F344 male rats.
Kushida H; Wakabayashi K; Sato H; Katami M; Kurosaka R; Nagao M
Cancer Lett; 1994 Aug; 83(1-2):31-5. PubMed ID: 8062230
[TBL] [Abstract][Full Text] [Related]
6. Effects of co-treatment of dextran sulfate sodium and MeIQx on genotoxicity and possible carcinogenicity in the colon of p53-deficient mice.
Okamura T; Ishii Y; Suzuki Y; Inoue T; Tasaki M; Kodama Y; Nohmi T; Mitsumori K; Umemura T; Nishikawa A
J Toxicol Sci; 2010 Oct; 35(5):731-41. PubMed ID: 20930467
[TBL] [Abstract][Full Text] [Related]
7. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse.
Dooley KL; Von Tungeln LS; Bucci T; Fu PP; Kadlubar FF
Cancer Lett; 1992 Mar; 62(3):205-9. PubMed ID: 1596864
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2-amino-3-methylimidazo [4,5-f]quinoline.
Morimura K; Salim EI; Yamamoto S; Wanibuchi H; Fukushima S
Cancer Lett; 1999 Apr; 138(1-2):81-5. PubMed ID: 10378777
[TBL] [Abstract][Full Text] [Related]
9. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver.
Mori Y; Koide A; Kobayashi Y; Furukawa F; Hirose M; Nishikawa A
Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma induction in LEC rats by a low dose of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Sone H; Wakabayashi K; Kushida H; Enomoto K; Mori M; Takeichi N; Tsuda H; Sugimura T; Nagao M
Jpn J Cancer Res; 1996 Jan; 87(1):25-9. PubMed ID: 8609044
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effects of carbon tetrachloride on in vivo mutagenicity in the liver of mice fed 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Okamura T; Ishii Y; Suzuki Y; Inoue T; Tasaki M; Kodama Y; Nohmi T; Mitsumori K; Umemura T; Nishikawa A
J Toxicol Sci; 2010 Oct; 35(5):709-20. PubMed ID: 20930465
[TBL] [Abstract][Full Text] [Related]
12. Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats.
Tsuda H; Sekine K; Uehara N; Takasuka N; Moore MA; Konno Y; Nakashita K; Degawa M
Cancer Lett; 1999 Sep; 143(2):229-34. PubMed ID: 10503909
[TBL] [Abstract][Full Text] [Related]
13. Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (A alphaC) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Okonogi H; Ushijima T; Shimizu H; Sugimura T; Nagao M
Cancer Lett; 1997 Jan; 111(1-2):105-9. PubMed ID: 9022134
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Min W; Lee CC; Salim EI; Wanibuchi H; Sukata T; Fukushima S
Cancer Lett; 1999 Jan; 135(2):137-44. PubMed ID: 10096421
[TBL] [Abstract][Full Text] [Related]
16. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Takasuka N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
Cancer Lett; 2003 Feb; 191(1):35-40. PubMed ID: 12609707
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Kato T; Ohgaki H; Hasegawa H; Sato S; Takayama S; Sugimura T
Carcinogenesis; 1988 Jan; 9(1):71-3. PubMed ID: 3335050
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.
Dass SB; Bucci TJ; Heflich RH; Casciano DA
Cancer Lett; 1999 Aug; 143(1):81-5. PubMed ID: 10465341
[TBL] [Abstract][Full Text] [Related]
19. Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.
Tsuda H; Takahashi S; Yamaguchi S; Ozaki K; Ito N
Carcinogenesis; 1990 Apr; 11(4):549-52. PubMed ID: 2322995
[TBL] [Abstract][Full Text] [Related]
20. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
